Risk-taking responses to crash experience: Evidence from China. [PDF]
Fang Z, Xu H, Mu Y.
europepmc +1 more source
When Nature Counts: Corporate Biodiversity Attention and Access to Bank Finance
ABSTRACT This paper investigates whether corporate attention to biodiversity influences firms' access to bank loans, an overlooked question in the emerging biodiversity–finance literature. Using a novel, text‐based measure constructed from 446 biodiversity‐related keywords and applied to Chinese A‐share listed firms from 2000 to 2023, we show that ...
Ruxiao Li +3 more
wiley +1 more source
The Health of Nations Fund: Financing global drug development. [PDF]
Cho J +4 more
europepmc +1 more source
The Impact of Green Innovation and Green Finance on Corporate ESG Performance
ABSTRACT Amid the transition towards a low‐carbon economy and the pursuit of sustainable development goals, ESG performance has become a key indicator of long‐term corporate sustainability. Drawing on data from Chinese A‐share listed companies between 2012 and 2022, this study examines how green innovation and green finance affect corporate ESG ...
Zhaoke Feng, Chaminda Wijethilake
wiley +1 more source
Entropy-Driven Volatility Prediction for ETF Quantitative Investment in the Chinese Stock Market: A Machine Learning Framework for Barbell Strategy Optimization. [PDF]
Yan K, Yue Z, He Q, Li Y.
europepmc +1 more source
Retailer's inventory-based financing with bounded advance rates: Interplay between wholesale price contract and loan menu. [PDF]
Dang Y, Tian J, Liao J, Tang M, Tian C.
europepmc +1 more source
An alternative strategy for balancing profit maximization and risk reduction. [PDF]
El Khatib Y, Mukhamedova F.
europepmc +1 more source
The Governance Gap: Democratizing Drug Development Through Decision Architecture. [PDF]
Rayner CR +16 more
europepmc +1 more source
A mechanism-guided simulation framework for synthetic tax-risk data: Constraint validation and reproducible benchmarking. [PDF]
Fan X.
europepmc +1 more source

